KRAS and colorectal cancer: Over the past years, it has been reported that chronic inflammation, leading to early stages of colorectal cancer, is characterized by the production of pro-inflammatory cytokines, which can induce a) mutations in oncogenes and tumor suppressor genes (APC, p53, K-ras), and b) genomic instability through a variety of mechanisms [48].